These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1225812)

  • 1. [Drug therapy of venopathies].
    Esser W
    Fortschr Med; 1975 Oct; 93(30):1506-7. PubMed ID: 1225812
    [No Abstract]   [Full Text] [Related]  

  • 2. [Supportive drug therapy of varicose veins with venelbin].
    Ohler R
    Fortschr Med; 1978 Nov; 96(42):2173-7. PubMed ID: 711110
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of Venoruton on the lower-leg volume in normal persons and in patients with venous-flow disorders].
    Bopp J
    Med Welt; 1977 Oct; 28(41):1660-4. PubMed ID: 927128
    [No Abstract]   [Full Text] [Related]  

  • 4. [Venalot used in therapy of phlebopathies].
    Lacativa AS
    Med Welt; 1980 May; 31(19):727-9. PubMed ID: 7421506
    [No Abstract]   [Full Text] [Related]  

  • 5. [Venoruton--used not only in venopathies? Symposium on O-(beta-hydroxyethyl)-rutoside (=Venoruton) in vascular diseases].
    ZFA (Stuttgart); 1981 Sep; 57(26):1758-60. PubMed ID: 7303836
    [No Abstract]   [Full Text] [Related]  

  • 6. [Sclerosing of varicose veins and additional medication. Are disease course and results affected by combined therapy? An experience report].
    Böhme D
    ZFA (Stuttgart); 1980 May; 56(13):953-9. PubMed ID: 7415464
    [No Abstract]   [Full Text] [Related]  

  • 7. [Further pharmacologic possibilities in the therapy of phlebopathies of the lower limbs].
    Bagliani A; Vittori F
    Clin Ter; 1972 May; 61(4):321-40. PubMed ID: 5065782
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of large doses of a flavonoid O-(betahydroxyethyl)-rutoside on some aspects of venous circulation].
    Forconi S; Guerrini M
    Clin Ter; 1977 Feb; 80(3):229-55. PubMed ID: 852233
    [No Abstract]   [Full Text] [Related]  

  • 9. [On drug therapy of phlebopathies of the lower extremities with trihydroxyethylrutoside and trihydroxyethylrutoside associated with adrenochromomonosemicarbazone].
    Bagliani A; Taborelli R; Parravicini R
    Minerva Cardioangiol; 1973 Dec; 21(12):775-88. PubMed ID: 4780269
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical observations in drug treatment of venous diseases of the lower extremities].
    Panayotopoulos S; Charissiadis E; Panayotopoulos E
    Med Monatsschr; 1969 Dec; 23(12):556-8. PubMed ID: 5394231
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapeutic experiences with Vasoforte].
    Schrüffer H
    Z Allgemeinmed; 1973 Aug; 49(23):1103-5. PubMed ID: 4731530
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative investigations on the treatment of the varicose syndrome with 4-methyl-6,7-(bis-beta-diethyl-aminoethoxy)-coumarine hydrochloride (oxamarine), with the disodium salt of disulphuric ester of 4-methyl-aesculetol and with tri-hydroxy-ethylrutoside (troxerutin).
    Frandoli G; Turazza G; Spreafico PL
    Panminerva Med; 1972 Sep; 14(9):290-5. PubMed ID: 4618898
    [No Abstract]   [Full Text] [Related]  

  • 13. [On prolonged treatment of phlebopathic patients with a combination of vasoactive and vasoprotective drugs. Rheographic study].
    Rizzi B; Giacomini F; Terni E; Zullini ML
    Minerva Cardioangiol; 1971 Feb; 19(2):73-85. PubMed ID: 5572860
    [No Abstract]   [Full Text] [Related]  

  • 14. [Venous diseases and their treatment in gynecology].
    Häming B
    Z Allgemeinmed; 1972 Jan; 48(3):123-4. PubMed ID: 5015008
    [No Abstract]   [Full Text] [Related]  

  • 15. [Apropos of the drug therapy of varicose disease with a new synthetic vitamin P].
    Berson I
    Praxis; 1968 Aug; 57(34):1170-2. PubMed ID: 5756966
    [No Abstract]   [Full Text] [Related]  

  • 16. [Therapy of venopathies from viewpoint the dermatologist's].
    Schuster KH; Wolff E
    Z Allgemeinmed; 1975 Jan; 51(3):129-30. PubMed ID: 1130106
    [No Abstract]   [Full Text] [Related]  

  • 17. [Modifications induced by long-term treatment with high doses of 0-(beta-hydroxyethyl)-rutoside in chronic venous insufficiency].
    Barbarino C; Pezzangora V
    Vasa Suppl; 1989; 27():120. PubMed ID: 2623482
    [No Abstract]   [Full Text] [Related]  

  • 18. [Aescine (1328 A.N.) in venous pathology].
    Fredenucci P
    Mars Med; 1971; 108(6):495-7. PubMed ID: 5165640
    [No Abstract]   [Full Text] [Related]  

  • 19. [Dosage of O-beta hydroxyethylrutoside in chronic venous insufficiency].
    Stemmer R; Furderer CR
    Phlebologie; 1986; 39(4):995-1003. PubMed ID: 3562569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A new application technic in the local management of vein diseases and traumatic lesions of the locomotor system].
    Lotz H
    Landarzt; 1967 Nov; 43(32):1591-3. PubMed ID: 5594629
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.